M.A. Med Alliance S.A.
$3.6M 0 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Aurinia Pharma U.S., Inc.
Aurinia Pharma U.S., Inc. reported $3,582,851.91 across General Payments, Research, and Ownership to 13,556 physicians and teaching hospitals across 13,909 transactions.
- $3.6M Top quartile payer
- All-tracks total
- 13,909 Top 10% volume
- Transactions
- 13,556 Top 10% reach
- Recipients
- −$695.8K
- General Payments vs PY2023
Aurinia Pharma U.S., Inc. reported $3,582,851.91 across all CMS Open Payments tracks (General + Research + Ownership) to 13,556 physicians and teaching hospitals in Program Year 2024 - ranking #324 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,026,979.45, averaging $264.30 per recipient.
How Aurinia Pharma U.S., Inc.'s $3.6M all-tracks total breaks down
Aurinia Pharma U.S., Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
B
80/100
Total payments
F
43/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer aurinia-pharma-u-s-inc Aurinia Pharma U.S., Inc.
$3.6M · #324/1,925 · 0.0% industry · PY2024
- TOT $3.6M
- RANK #324
- SHARE 0.0%
- TXN 13,909
- RCP 13,556
- CAT 6
- GEN $1.0M
- ΔGEN −$695.8K
- TOP1 8.7%
- PY 2024
Volume peers
Nearest volume peer: M.A. Med Alliance S.A. ($3.6M)
Aurinia Pharma U.S., Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Aurinia Pharma U.S., Inc.'s CMS-reported General Payments decreased by $695.8K (−40.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AURINIA PHARMA U.S., INC.PY2023: AURINIA PHARMA U.S., INC.PY2024: Aurinia Pharma U.S., Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,722,758.41
- PY2024
- $1,026,979.45
What the Data Shows for Aurinia Pharma U.S., Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Aurinia Pharma U.S., Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 6-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $401.8K, accounting for 39.1% of this company's General Payments and 165 transactions.
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Aurinia Pharma U.S., Inc.'s 6-category general-payment breakdown at $401.8K, 39.1% of the reported total.
Aurinia Pharma U.S., Inc. reports 6 general-payment categories - the top three are Compensation for Services Other Than Consulting (39.1%), Food and Beverage (34.6%), and Grant (9.6%). The remaining 3 categories make up 16.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Aurinia Pharma U.S., Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $401.8K | 165 | 39.1% |
| Food and Beverage | $354.8K | 12,934 | 34.6% |
| Grant | $98.1K | 9 | 9.6% |
| Travel and Lodging | $87.7K | 312 | 8.5% |
| Consulting Fee | $82.7K | 26 | 8.1% |
| Education | $1.8K | 110 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $247,193.85 (24.1%) of $1,026,979.45 in this company's General Payments records across 5,254 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Aurinia Pharma U.S., Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Tina Kochar
$89,265.44 across 117 reported transactions
- 2
German Hernandez
$67,059.49 across 105 reported transactions
- 3
Hospital of the Univ of Penna
$33,000.00 across 3 reported transactions
- 4
Mohammed Ahmed
$29,580.70 across 42 reported transactions
- 5
Jorge Larranaga
$28,288.22 across 52 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Aurinia Pharma U.S., Inc. ranks #324 of 1,925 by total payments (top 17% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,549 of 1,838 by HHI (bottom 16% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Cgg Medical Inc : $149.7K total payments, HHI 214
- QOL Medical, LLC : $693.7K total payments, HHI 214
- Mentor Worldwide LLC : $1.0M total payments, HHI 213
- Avation Medical, Inc. : $4.0K total payments, HHI 213
- US Oncology Corporate, Inc. : $55.9K total payments, HHI 209
- Southern Edge Orthopaedics, Inc. : $9.9K total payments, HHI 207
- Aurinia Pharma U.S., Inc. (this company) : $1.0M total payments, HHI 207
- Darby Dental Supply, LLC : $229.5K total payments, HHI 207
- Incyte Corporation : $13.1M total payments, HHI 206
- Mitsubishi Tanabe Pharma America, Inc. : $415.3K total payments, HHI 205
- Ferring Pharmaceuticals Inc. : $2.0M total payments, HHI 202
- Argentum Medical : $3.5K total payments, HHI 201
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Aurinia Pharma U.S., Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Aurinia Pharma U.S., Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Aurinia Pharma U.S., Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Ortho Development Corporation
$3.6M 924 recipients
Compare payment profiles
Ethicon Inc.
$3.5M 2,774 recipients
Compare payment profiles
Kowa Company, Ltd.
$3.5M 0 recipients
Compare payment profiles
Amplify Surgical, Inc.
$3.5M 66 recipients
Compare payment profiles
Merz North America, Inc.
$3.6M 14,831 recipients
Compare payment profiles
Put this to use
Aurinia Pharma U.S., Inc. ranks #324 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Aurinia Pharma U.S., Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Aurinia Pharma U.S., Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.